A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

被引：0
|
作者：
Hu, Ziyi [1 ]
Zhou, Tingting [1 ]
Wu, Fangrong [1 ]
Lin, Fan [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Nanjing Med Univ, Sch Basic Med Sci, Dept Cell Biol, Nanjing, Peoples R China
[2] Nanjing Med Univ, Inst Brain Tumors, Nanjing, Peoples R China
[3] Nanjing Med Univ, Key Lab Rare Metab Dis, Nanjing, Peoples R China
[4] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Peoples R China
[5] Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Peoples R China
来源：
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2021年 / 169期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.3791/62312
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The glioma stem cells (GSCs) are a small fraction of cancer cells which play essential roles in tumor initiation, angiogenesis, and drug resistance in glioblastoma (GBM), the most prevalent and devastating primary brain tumor. The presence of GSCs makes the GBM very refractory to most of individual targeted agents, so high-throughput screening methods are required to identify potential effective combination therapeutics. The protocol describes a simple workflow to enable rapid screening for potential combination therapy with synergistic interaction. The general steps of this workflow consist of establishing luciferase-tagged GSCs, preparing matrigel coated plates, combination drug screening, analyzing, and validating the results.
引用
收藏
页数：10
相关论文
共 50 条
  • [41] A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening
    Zhang, Liyang
    Liu, Fangkun
    Weygant, Nathaniel
    Zhang, Junxia
    Hu, Ping
    Qin, Zailong
    Yang, Jingxuan
    Cheng, Quan
    Fan, Fan
    Zeng, Yu
    Tang, Yongjian
    Li, Yusheng
    Tang, Anliu
    He, Fengqiong
    Peng, Jun
    Liao, Weihua
    Hu, Zhongliang
    Li, Min
    Liu, Zhixiong
    CANCER LETTERS, 2021, 500 : 87 - 97
  • [42] Characterization and High-Throughput Drug Screening of a Cardiomyopathy Using Cardiomyocytes From Patient-Derived Induced Pluripotent Stem Cells
    Rowland, Teisha J.
    Hashem, Sherin I.
    Jones, Kenneth L.
    Adler, Eric D.
    LaBarbera, Daniel V.
    Mestroni, Luisa
    Taylor, Matthew R.
    CIRCULATION, 2016, 134
  • [43] Characterization and High-Throughput Drug Screening of a Cardiomyopathy Using Cardiomyocytes From Patient-Derived Induced Pluripotent Stem Cells
    Rowland, Teisha J.
    Hashem, Sherin I.
    Jones, Kenneth L.
    Adler, Eric D.
    LaBarbera, Daniel V.
    Mestroni, Luisa
    Taylor, Matthew R.
    CIRCULATION, 2016, 134
  • [44] Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells
    Sugimoto, Keiki
    Hayakawa, Fumihiko
    Shimada, Satoko
    Morishita, Takanobu
    Shimada, Kazuyuki
    Katakai, Tomoya
    Tomita, Akihiro
    Kiyoi, Hitoshi
    Naoe, Tomoki
    SCIENTIFIC REPORTS, 2015, 5
  • [45] Predicting breast cancer therapy response using a patient-derived xenograft organoid screening platform
    Guillen, Katrin P.
    Scherer, Sandra D.
    Qiao, Yi
    Pathi, Satya S.
    Graham, James M.
    Fujita, Maihi
    DeRose, Yoko S.
    Gertz, Jason
    Marth, Gabor T.
    Varley, Katherine E.
    Welm, Alana L.
    Welm, Bryan E.
    CANCER RESEARCH, 2018, 78 (13)
  • [46] Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells
    Keiki Sugimoto
    Fumihiko Hayakawa
    Satoko Shimada
    Takanobu Morishita
    Kazuyuki Shimada
    Tomoya Katakai
    Akihiro Tomita
    Hitoshi Kiyoi
    Tomoki Naoe
    Scientific Reports, 5
  • [47] Recruitment of bone marrow derived cells during anti-angiogenic therapy in GBM: The potential of combination strategies
    Boer, Jennifer C.
    Walenkamp, Annemiek M. E.
    den Dunnen, Wilfred F. A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 92 (01) : 38 - 48
  • [48] The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells
    Trong, Philip Dao
    Jungwirth, Gerhard
    Unterberg, Andreas
    Herold-Mende, Christel
    Warta, Rolf
    CELLS, 2023, 12 (08)
  • [49] IDENTIFICATION OF TIME-DEPENDENT PHENOTYPIC SHIFTS IN PATIENT-DERIVED GLIOMA STEM-LIKE CELLS AFTER CHEMORADIOTHERAPY
    Van Eupen, L.
    De Visser, Y.
    Gonzalez-Blas, C. Bravo
    Cole, B.
    Loers, J.
    Derweduwe, M.
    Claeys, A.
    Tabury, K.
    Primac, I
    Vermeirssen, V.
    De Smet, F.
    Quintens, R.
    NEURO-ONCOLOGY, 2024, 26 : V33 - V33
  • [50] DRUG SCREEN IN PATIENT-DERIVED IDHMUT GLIOMA STEM CELLS IDENTIFIES SEVERAL FDA-APPROVED ANTINEOPLASTIC AGENTS
    Trong, Philip Dao
    Pusch, Stefan
    Unterberg, Andreas
    Herold-Mende, Christel
    Warta, Rolf
    NEURO-ONCOLOGY, 2019, 21 : 67 - 68
12345